Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by wexworthon Oct 07, 2020 11:51am
287 Views
Post# 31680151

US legislation and positive impact on Sirona

US legislation and positive impact on SironaHydroquinone is out. Sirona's 1067 is in. Rodan and Fields chose this because it is absolutely the best product in the world to safely replace Hydroquinone. The clinical study will be officially published soon enough, and after that, we should be prepared for anything anytime from Sirona and potential new partners. One thing is for sure, as of September, Hydroquinone is out for Rodan and if you are able to reach customer service, they will tell you that a replacement will be out soon. The investigations and research on the ground to source all kinds of business intelligence on this introduction are pointing very heavily in the direction of an imminent launch. BUT we won't know for sure until they announce (or not)...
Bullboard Posts